Back to top

Astellas Pharma (ALPMF) Gets a Buy from Goldman Sachs

Goldman Sachs analyst maintained a Buy rating on Astellas Pharma today and set a price target of Yen3,000.00. The word on The Street in general, su...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astellas Pharma Inc. (ALPMY)